Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Galazka, Andrew
74  Ergebnisse:
Personensuche X
?
1

Twenty Years of Subcutaneous Interferon-Beta-1a for Multipl..:

Freedman, Mark S. ; Coyle, Patricia K. ; Hellwig, Kerstin...
Neurology and Therapy.  13 (2024)  2 - p. 283-322 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Updated Post-Approval Safety of Cladribine Tablets in the T..:

Leist, Thomas ; Giovannoni, Gavin ; Jack, Dominic..
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
3

Post-Approval Safety of Cladribine Tablets in the Treatment..:

Giovannoni, Gavin ; Leist, Thomas ; Jack, Dominic...
Multiple Sclerosis and Related Disorders.  80 (2023)  - p. 105309 , 2023
Link: https://doi.org/10.1016/..
 
?
4

The Effect of Cladribine Tablets in People With More Active..:

Vermersch, Patrick ; Galazka, Andrew ; Dangond, Fernando...
Neurodegenerative Disease Management.  12 (2022)  6 - p. 285-293 , 2022
Link: https://doi.org/10.2217/..
 
?
5

Relapses in People With Multiple Sclerosis Treated With Cla..:

Stefano, Nicola De ; Sormani, Maria Pia ; Giovannoni, Gavin...
Neurodegenerative Disease Management.  12 (2022)  6 - p. 303-310 , 2022
Link: https://doi.org/10.2217/..
 
?
6

Outcomes of COVID-19 in people with multiple sclerosis trea..:

Jack, Dominic ; Damian, Doris ; Nolting, Axel.
Multiple Sclerosis and Related Disorders.  51 (2021)  - p. 102996 , 2021
Link: https://doi.org/10.1016/..
 
?
7

Cladribine as a Potential Object of Nucleoside Transporter-..:

Hermann, Robert ; Krajcsi, Peter ; Fluck, Markus...
Clinical Pharmacokinetics.  61 (2021)  2 - p. 167-187 , 2021
Link: https://doi.org/10.1007/..
 
?
8

COVID-19 in patients with multiple sclerosis treated with c..:

Jack, Dominic ; Damian, Doris ; Nolting, Axel.
Multiple Sclerosis and Related Disorders.  51 (2021)  - p. 102929 , 2021
Link: https://doi.org/10.1016/..
 
?
9

Efficacy of cladribine tablets in high disease activity pat..:

Vermersch, Patrick ; Galazka, Andrew ; Dangond, Fernando...
Current Medical Research and Opinion.  37 (2021)  3 - p. 459-464 , 2021
Link: https://doi.org/10.1080/..
 
?
10

Review of Transporter Substrate, Inhibitor, and Inducer Cha..:

Hermann, Robert ; Krajcsi, Peter ; Fluck, Markus...
Clinical Pharmacokinetics.  60 (2021)  12 - p. 1509-1535 , 2021
Link: https://doi.org/10.1007/..
 
?
11

Updated Post-Approval Safety of Cladribine Tablets in the T..:

Giovannoni, Gavin ; Berger, Joseph ; Leist, Thomas...
Neurology.  96 (2021)  15_supplement - p. , 2021
Link: https://doi.org/10.1212/..
 
?
12

Early MRI outcomes in participants with a first clinical de..:

Freedman, Mark S ; Coyle, Patricia K ; Comi, Giancarlo...
Multiple Sclerosis Journal - Experimental, Translational and Clinical.  7 (2021)  1 - p. 205521732199085 , 2021
Link: https://doi.org/10.1177/..
 
?
13

Subgroup analysis of clinical and MRI outcomes in participa..:

Cree, Bruce A.C. ; Bowen, James D. ; Hartung, Hans-Peter...
Multiple Sclerosis and Related Disorders.  49 (2021)  - p. 102695 , 2021
Link: https://doi.org/10.1016/..
 
?
14

Integrated Lymphopenia Analysis in Younger and Older Patien..:

Giovannoni, Gavin ; Coyle, Patricia K. ; Vermersch, Patrick...
Frontiers in Immunology.  12 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
15

Analysis of frequency and severity of relapses in multiple ..:

De Stefano, Nicola ; Sormani, Maria Pia ; Giovannoni, Gavin...
Multiple Sclerosis Journal.  28 (2021)  1 - p. 111-120 , 2021
Link: https://doi.org/10.1177/..
 
1-15